Published in Clin Gastroenterol Hepatol on November 09, 2010
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19
Clinical and molecular features of young-onset colorectal cancer. World J Gastroenterol (2016) 0.91
Anticipation in lynch syndrome: where we are where we go. Curr Genomics (2011) 0.87
The genetic basis of Lynch syndrome and its implications for clinical practice and risk management. Appl Clin Genet (2014) 0.84
Interval colon cancer in a Lynch syndrome patient under annual colonoscopic surveillance: a case for advanced imaging techniques? BMC Gastroenterol (2012) 0.83
Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case. Fam Cancer (2015) 0.81
Chemoprevention of hereditary colon cancers: time for new strategies. Nat Rev Gastroenterol Hepatol (2016) 0.80
Speed kills. Clin Gastroenterol Hepatol (2010) 0.78
Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci (2014) 0.78
Lynch syndrome: new tales from the crypt. Lancet Oncol (2012) 0.77
Quality of colonoscopy in Lynch syndrome. Endosc Int Open (2014) 0.77
Hereditary Colorectal Cancer: Genetics and Screening. Surg Clin North Am (2015) 0.77
Recent advances in understanding Lynch syndrome. F1000Res (2016) 0.75
Total colectomy for multiple metachronous colon cancers in a patient with Lynch syndrome. Surg Case Rep (2015) 0.75
Clinical guideline seom: hereditary colorectal cancer. Clin Transl Oncol (2015) 0.75
Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report. World J Surg Oncol (2017) 0.75
Approach to Lynch Syndrome for the Gastroenterologist. Dig Dis Sci (2016) 0.75
Hereditary colorectal cancer. N Engl J Med (2003) 11.86
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg (1999) 1.51
Hereditary non-polyposis colorectal cancer--morphologies, genes and mutations. Mutat Res (1994) 1.46
Development of colorectal tumors in colonoscopic surveillance in Lynch syndrome. Gastroenterology (2007) 1.36
Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol (2008) 1.32
Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum (1998) 1.12
Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06
New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gastroenterology (2006) 1.04
Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther (2007) 1.00
Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening. Gastroenterology (1995) 0.93
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64
Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA (2006) 4.34
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res (2006) 3.81
Small changes in expression affect predisposition to tumorigenesis. Nat Genet (2001) 3.37
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci U S A (2004) 3.35
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27
Clinically relevant changes in family history of cancer over time. JAMA (2011) 3.18
Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med (2002) 3.16
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10
Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol (2004) 2.92
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood (2012) 2.65
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2008) 2.47
Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol (2006) 2.34
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13
Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology (2004) 2.06
Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test (2002) 1.81
Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma. Leuk Lymphoma (2006) 1.68
High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res (2003) 1.68
Risk of colorectal cancer in juvenile polyposis. Gut (2007) 1.64
Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology (2004) 1.62
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol (2006) 1.57
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia. Leuk Lymphoma (2011) 1.45
Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology (2002) 1.45
Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors. Br J Haematol (2005) 1.41
Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med (2004) 1.39
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol (2013) 1.35
Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol (2008) 1.32
Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer (2005) 1.26
Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer (2009) 1.26
Juvenile polyposis syndrome. World J Gastroenterol (2011) 1.26
Familial adenomatous polyposis. Gastrointest Endosc (2003) 1.22
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. Clin Cancer Res (2005) 1.21
Gastrointestinal polyposis syndromes. Curr Mol Med (2007) 1.18
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res (2008) 1.17
Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol (2011) 1.17
Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A (2003) 1.15
Characterization of chronic myeloid leukemia stem cells. Am J Hematol (2011) 1.15
Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.12
Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol Ther (2003) 1.11
RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet (2007) 1.10
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res (2008) 1.09
Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol (2014) 1.09
Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol (2012) 1.08
SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome. Clin Cancer Res (2010) 1.08
Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut (2012) 1.07
GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS One (2011) 1.05
Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet (2003) 1.04
Colorectal cancer screening. J Natl Compr Canc Netw (2013) 1.02
Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology (2004) 1.01
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biol Blood Marrow Transplant (2006) 0.99
Ethnic and sex disparities in colorectal neoplasia among Hispanic patients undergoing screening colonoscopy. Clin Gastroenterol Hepatol (2012) 0.98
High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res (2002) 0.98
Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol (2002) 0.97
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev (2005) 0.97
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc (2014) 0.94
Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer (2010) 0.94
Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas. Pancreas (2011) 0.93
Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum (2009) 0.93
Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res (2011) 0.93
Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial. Transplantation (2005) 0.93
Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol (2003) 0.93
Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Cancer Genet Cytogenet (2007) 0.92
"You don't have to keep everything on paper": African American women's use of family health history tools. J Community Genet (2013) 0.92
Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. Epigenetics (2009) 0.91
Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm Bowel Dis (2007) 0.91
Increased expression of cytoplasmic HuR in familial adenomatous polyposis. Cancer Biol Ther (2007) 0.91
Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011. Diagn Microbiol Infect Dis (2012) 0.90
Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas. Clin Cancer Res (2003) 0.90
Multiple colorectal neoplasms in X-linked agammaglobulinemia. Clin Gastroenterol Hepatol (2007) 0.90
Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am (2002) 0.90
Active recruitment increased enrollment in a hereditary cancer registry. J Clin Epidemiol (2004) 0.89
Patient perspective on the value of genetic counselling for familial pancreas cancer. Hered Cancer Clin Pract (2005) 0.89
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Mol Carcinog (2011) 0.89
Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis. J Mol Diagn (2011) 0.88